2018

1. Prospective randomized trial of 5 days azacitidine versus supportive care in patients with lower-risk myelodysplastic syndromes without 5q deletion and transfusion-dependent anemia

   Leukemia and Lymphoma, Vol. 59, Núm. 5, pp. 1095-1104